Research Articles | Page 91 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Impact of tobacco usage on disease outcome in myelodysplastic syndromes Apr 2015 Leuk Res myelodysplastic syndromes (MDS)
A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure Oct 2014 Leuk Res myelodysplastic syndromes (MDS)
Change of prognosis of patients with myelodysplastic syndromes during the last 30 years Apr 2015 Leuk Res myelodysplastic syndromes (MDS)
Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis Feb 2014 Leuk Res myelodysplastic syndromes (MDS)
Aplastic Anemia & MDS International Foundation: Bone Marrow Failure Disease Scientific Symposium 2014 Jan 2015 Leuk Res paroxysmal nocturnal hemoglobinuria (PNH)
Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemia Mar 2014 Leuk Res myelodysplastic syndromes (MDS)
Early treatment initiation in lower-risk myelodysplastic syndromes produces an earlier and higher rate of transfusion independence Aug 2017 Leuk Res myelodysplastic syndromes (MDS)
Myelodysplastic syndromes should been renamed as myelodysplastic neoplasms. Jan 2013 Leuk Res myelodysplastic syndromes (MDS)
The difficulty to define progression patterns in patients with early stage myelodysplastic syndromes and deletion 5q-New prognostic markers are needed Dec 2013 Leuk Res myelodysplastic syndromes (MDS)
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes. Jun 2015 Leuk Res myelodysplastic syndromes (MDS)
Share with addtoany.com.